Parties In Zantac MDL Propose Path To 2023 Bellwether Trials
The parties in sprawling multidistrict litigation over alleged links between the heartburn drug Zantac and various cancers presented a joint plan Monday for narrowing a field of more than 130,000 potential...To view the full article, register now.
Already a subscriber? Click here to view full article